Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP888312.RAxCx_4f2j1MjgDIVZIvHLJlNJI89hB-FfE1B_a_Yp7LA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP888312.RAxCx_4f2j1MjgDIVZIvHLJlNJI89hB-FfE1B_a_Yp7LA130_assertion type Assertion NP888312.RAxCx_4f2j1MjgDIVZIvHLJlNJI89hB-FfE1B_a_Yp7LA130_head.
- NP888312.RAxCx_4f2j1MjgDIVZIvHLJlNJI89hB-FfE1B_a_Yp7LA130_assertion description "[Finally, following an observation that the AD-associated mediator, PGD(2), upregulated AKR1C3 expression in PHKs, we used immunofluorescence to examine AKR1C3 expression in AD and psoriasis lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP888312.RAxCx_4f2j1MjgDIVZIvHLJlNJI89hB-FfE1B_a_Yp7LA130_provenance.
- NP888312.RAxCx_4f2j1MjgDIVZIvHLJlNJI89hB-FfE1B_a_Yp7LA130_assertion evidence source_evidence_literature NP888312.RAxCx_4f2j1MjgDIVZIvHLJlNJI89hB-FfE1B_a_Yp7LA130_provenance.
- NP888312.RAxCx_4f2j1MjgDIVZIvHLJlNJI89hB-FfE1B_a_Yp7LA130_assertion SIO_000772 22170488 NP888312.RAxCx_4f2j1MjgDIVZIvHLJlNJI89hB-FfE1B_a_Yp7LA130_provenance.
- NP888312.RAxCx_4f2j1MjgDIVZIvHLJlNJI89hB-FfE1B_a_Yp7LA130_assertion wasDerivedFrom befree-20150227 NP888312.RAxCx_4f2j1MjgDIVZIvHLJlNJI89hB-FfE1B_a_Yp7LA130_provenance.
- NP888312.RAxCx_4f2j1MjgDIVZIvHLJlNJI89hB-FfE1B_a_Yp7LA130_assertion wasGeneratedBy ECO_0000203 NP888312.RAxCx_4f2j1MjgDIVZIvHLJlNJI89hB-FfE1B_a_Yp7LA130_provenance.